Author

L Zahradová

Observed names: L Zahradova, L. ZAHRADOVA, L. Zahradova, L. Zahradová

Observed institutions: University of Ostrava, Masaryk University, University Hospital Ostrava, University Hospital Brno

OpenAlex ID: A5111867455

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

2013 · L. Pour, S. Sevcikova, et al. · Haematologica · 186

PDF

Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results

2012 · L. ZAHRADOVA, K. MOLLOVA, et al. · Neoplasma · 36

PDF

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance

2009 · L. KOVAROVA, I. BURESOVA, et al. · Neoplasma · 22

Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation

2010 · H. Greslikova, R. Zaoralova, et al. · Neoplasma · 19

PDF

[Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].

2011 · Z Adam, R Koukalová, et al. · PubMed · 14

[Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature].

2012 · Z Adam, P Szturz, et al. · PubMed · 12

Dendritic cell counts and their subsets during treatment of multiple myeloma.

2007 · L Kovarova, T Buchler, et al. · PubMed · 12

[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].

2012 · Z Adam, L Pour, et al. · PubMed · 7

[Kidney failure in a patient with chronic B-lymphocytic leukaemia (B-CLL) with underlying cast nephropathy. The value of free immunoglobulin light chain identification for early diagnosis of this complication].

2011 · Z Adam, S Stepánková, et al. · PubMed · 6

Prognostic significance of morphological assessment of plasma cells in multiple myeloma

2011 · M. AL-SAHMANI, I. TRNAVSKA, et al. · Neoplasma · 6

[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].

2010 · Z Adam, L Pour, et al. · PubMed · 6

Isolation and Expansion of Allogeneic Myeloma-Specific Interferon-Gamma Producing T Cells for Adoptive Immunotherapy

2006 · D. Ocadlikova, L. Zahradova, et al. · Medical Oncology · 6

[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].

2012 · Z Adam, Z Rehák, et al. · PubMed · 4

[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis].

2010 · Z Adam, L Pour, et al. · PubMed · 4

[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells].

2009 · D Ocadlíková, L Zahradová, et al. · PubMed · 3

[Eyelids with yellow granulomas and cough - periocular xanthogranuloma associated with adult-onset asthma. A case study and an overview of clinical forms of juvenile xanthogranuloma and its therapy].

2012 · Zdenek Adam, K Veselý, et al. · PubMed · 2

[The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].

2012 · Z Adam, M Elleder, et al. · PubMed · 2

Comparison of whole-body low-dose computed tomography and conventional radiography in the staging of multiple myeloma

2015 · H. Plonkova, K. Miklosova, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

[Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].

2012 · Z Adam, M Stork, et al. · PubMed · 1

Interpretation difficulties in electrophoresis and immunofixation findings in patients with multiple myeloma after autologous transplantation

2017 · P Kušnierová, D Zeman, et al. · Klinická biochemie a metabolismus

PDF

[Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall].

2012 · Z Adam, M Matýšková, et al. · PubMed

[MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].

2011 · J Vanícek, Z Adam, et al. · PubMed

[Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen].

2011 · P Szturz, R Jakubcová, et al. · PubMed

B228 Gain 1q21 Versus Velcade- and Thalidomide-Based Regimens

2009 · P Nemec, H Greslikova, et al. · Clinical Lymphoma & Myeloma

A251 Better Efficacy/Toxicity Ratio of Velcade-Based Regimens

2009 · R Hajek, L Zahradova, et al. · Clinical Lymphoma & Myeloma

Works count: 30

Citation count: 349

H-index: 7

I10-index: 7